Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


3 Eur Respir J
1 J Antimicrob Chemother
1 J Clin Microbiol
1 J Infect Dis
1 Lancet
2 Lancet Respir Med
2 N Engl J Med
4 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Eur Respir J

  1. COLLIN SM, de Vries G, Lonnroth K, Migliori GB, et al
    Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes.
    Eur Respir J. 2018 Oct 11. pii: 13993003.01449-2018.
    PubMed     Text format     Abstract available

  2. LAW S, Daftary A, O'Donnell M, Padayatchi N, et al
    Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review.
    Eur Respir J. 2018 Oct 11. pii: 13993003.01030-2018.
    PubMed     Text format     Abstract available

  3. GANDHI NR, Brust JCM, Shah NS
    A new era for treatment of drug-resistant tuberculosis.
    Eur Respir J. 2018;52.
    PubMed     Text format    

    J Antimicrob Chemother

  4. DOAN TN, Fox GJ, Meehan MT, Scott N, et al
    Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
    J Antimicrob Chemother. 2018 Oct 5. pii: 5116208. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Clin Microbiol

  5. BERHANU RH, David A, da Silva P, Shearer K, et al
    Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott Real Time MTB for the diagnosis of pulmonary tuberculosis in a high HIV burden setting.
    J Clin Microbiol. 2018 Oct 10. pii: JCM.00560-18. doi: 10.1128/JCM.00560.
    PubMed     Text format     Abstract available

    J Infect Dis

  6. AMARAL EP, Machado de Salles E, Barbosa Bomfim CC, Salgado RM, et al
    Inhibiting Adenosine Receptor Signaling Promotes Accumulation of Effector CD4+ T Cells in the Lung Parenchyma During Severe Tuberculosis.
    J Infect Dis. 2018 Oct 11. pii: 5126506. doi: 10.1093.
    PubMed     Text format     Abstract available


    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    PubMed     Text format    

    Lancet Respir Med

    Tobacco control, lung cancer, and tuberculosis in Singapore.
    Lancet Respir Med. 2018;6:741-742.
    PubMed     Text format    

    United to end tuberculosis.
    Lancet Respir Med. 2018 Oct 5. pii: S2213-2600(18)30416.
    PubMed     Text format    

    N Engl J Med

  10. RUBIN AK, Burk KS, Staller K, Kunitake H, et al
    Case 30-2018: A 66-Year-Old Woman with Chronic Abdominal Pain.
    N Engl J Med. 2018;379:1263-1272.
    PubMed     Text format    

  11. OKAMOTO K, Hatakeyama S
    Tuberculous Peritonitis.
    N Engl J Med. 2018;379:e20.
    PubMed     Text format    

    PLoS One

  12. KIMUDA SG, Biraro IA, Bagaya BS, Raynes JG, et al
    Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance.
    PLoS One. 2018;13:e0205102.
    PubMed     Text format     Abstract available

  13. COLLINS JM, Walker DI, Jones DP, Tukvadze N, et al
    High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
    PLoS One. 2018;13:e0205398.
    PubMed     Text format     Abstract available

  14. VAN DE BERG S, Jansen-Aaldring N, de Vries G, van den Hof S, et al
    Patient support for tuberculosis patients in low-incidence countries: A systematic review.
    PLoS One. 2018;13:e0205433.
    PubMed     Text format     Abstract available

  15. WU K, Koo J, Jiang X, Chen R, et al
    Correction: Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R.
    PLoS One. 2018;13:e0205424.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.